Japan's Covid-19 cases defy Asia rebound, yet fears remain for winter wave

New daily infections have slowed to fewer than one per million people, the least among major economies except China, and fatalities have fallen to zero in recent days

Omicron, Japan Airport, Coronavirus, Covid
Closed doors at a departure hall of Narita international airport a day after Japan closed its borders to prevent the spread of Omicron variant. The country reported its first Omicron case on Tuesday (Photo: Reuters)
Reuters
4 min read Last Updated : Dec 09 2021 | 10:31 AM IST
Japan's COVID-19 infections are falling in contrast with rebounds in other parts of Asia, baffling experts.

New daily infections have slowed to fewer than one per million people, the least among major economies except China, and fatalities have fallen to zero in recent days.

South Korea, with similar vaccination coverage https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access, is seeing record infections. Cases remain elevated in Singapore and are rising again in Australia as authorities there relax stringent controls on movement.

One new hypothesis to explain the divergence is that the type of coronavirus dominant in Japan evolved in a way that short-circuited its ability to replicate.

Ituro Inoue, a professor at Japan's National Institute of Genetics, said that subvariant of Delta, known as AY.29, now may be
conferring some immunity in the population.

"I think AY.29 is protecting us from other strains," Inoue said, cautioning that his research remained a theory.
"I'm not 100% confident."

Paul Griffin, a professor at the University of Queensland, said differences in case loads between countries resulted from a complex mix of weather, population density, and varying strategies to fight the pandemic.

"We do need to try and take learnings away from other countries, but we shouldn't assume the same experience from country to country, because there are all those variables," Griffin said.

"Some countries are using strategies in addition to vaccination to control the spread, whether it's simple measures on hand hygiene, social distancing, and the use of masks and whether that's mandatory or voluntary."
 
Japan never locked down in the way that many countries did, but it also never let up on behavioural edicts and border restrictions employed before vaccines arrived.

"Wearing masks and personal hygiene rituals are still the same and important," said Kazuaki Jindai, a researcher at Tohoku University. "The vaccine is a crucial aspect of prevention but not the silver bullet."

Even accounting for vaccines and masking, some think the speed of the decline of cases in Japan is a matter of timing.

Japan's late start on vaccination means that the potency of the shots are still strong. Others point to seasonal trends, that the virus tends to crest and fall in two-month intervals.
 
WINTER IS COMING

Prime Minister Fumio Kishida is leaving little to chance as Japan enters its winter months, which last year saw a deadly infection wave that started in the colder north. He ordered borders shut last week to keep out the Omicron variant of the virus, discovered four times so far in Japan.

In contrast, Australia is going ahead with plans to reopen https://www.reuters.com/world/asia-pacific/australia-omicron-variant-spreads-testing-reopening-plans-2021-12-04 the economy. Now that the country has hit its vaccination targets and with the arrival of COVID-19 therapeutics, it is time to tolerate an uptick in cases, Griffin said.

"Hopefully locking down is something that we reserve for extenuating circumstances," he said.

Whatever the cause of the decline in cases in Japan, Kishida says it is important to prepare for the worst. Booster shots started last week, and the government has increased hospital capacity by more than 30% since some patients died at home during a fifth wave in August, the worst so far.

Researcher Jindai welcomes those preparations but worries about how they will be implemented and whether Japan can shore up its management of healthcare data, which has been a weak point.

"If the ICU beds are full, that means all downstream healthcare will be compromised," said Jindai, who also works as a physician in Kanagawa prefecture, south of Tokyo. "Until we have the sixth wave in front of us, we can't be sure if those measures worked or not."

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus Vaccine

Next Story